期刊
LEUKEMIA
卷 20, 期 10, 页码 1690-1700出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/sj.leu.2404335
关键词
hematopoietic cell transplantation; nonmyeloablative conditioning; donor chimerism; T-cells; NK cells
资金
- NCI NIH HHS [CA18029, CA78902, P01 CA078902, CA15704] Funding Source: Medline
- NHLBI NIH HHS [HL36444] Funding Source: Medline
- NIDDK NIH HHS [DK42716] Funding Source: Medline
Allogeneic hematopoietic cell transplantation ( HCT) following nonmyeloablative conditioning has been extensively evaluated in patients with hematologic malignancies who are ineligible for conventional HCT because of age or medical comorbidities. Nonmyeloablative regimens have led to an initial state of mixed hematopoietic chimerism defined as coexistence of donor- and host-derived hematopoiesis. While nonmyeloablative regimens have been associated with reduced regimen-related toxicities in comparison with conventional myeloablative conditioning, graft rejection, graft-versus-host disease ( GVHD), and disease progression have remained significant challenges. In this article, after briefly introducing current techniques for chimerism assessment, we describe factors affecting donor chimerism levels after nonmyeloablative conditioning, and then review data suggesting that chimerism assessment early after HCT might help identify patients at risk for graft rejection, GVHD and relapse/progression. Finally, we discuss how these observations have opened the way to further research protocols evaluating manipulation of postgrafting immunosuppression, and/or infusion of donor immune cells.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据